Heparin
Unfractionated Heparin
NADAC/unit
$1.1225
Active Shortage
Tier 1: 78.4%
PA Req: 100.9%
9 Manufacturers
36 ANDAs
Active Shortages
2025-04-29 Discontinuation of the manufacture of the drug., Hospira, Inc., a Pfizer Company
2017-11-14 Product Discontinued, Baxter Healthcare
2017-11-14 Estimated recovery: April 2026, Baxter Healthcare
2017-11-14 Check wholesalers for inventory, Fresenius Kabi USA, LLC
2017-11-14 Check wholesalers for inventory, Fresenius Kabi USA, LLC
Market Intelligence
2024-09-11 Class I Recall: Baxter Healthcare Corporation
2023-03-15 Class II Recall: Sagent Pharmaceuticals Inc
2023-01-11 Class II Recall: Pfizer Inc.
Generic Manufacturers
B BRAUN MEDICAL INCBAXTER HEALTHCARE CORPBE PHARMACEUTICALS AGEMERGE BIOSCIENCE PTE LTDFRESENIUS KABI USA LLCGLAND PHARMA LTDHIKMA PHARMACEUTICALS USA INCHOSPIRA INCPFIZER INCPHARMOBEDIENT CONSULTING LLCPLANO PHARMACEUTICALS INCSAGENT PHARMACEUTICALS INCSHENZHEN TECHDOW PHARMACEUTICAL CO LTD
Explore in the Ecosystem
Data sourced from CMS NADAC, FDA Orange Book, CMS Part D Formulary, CMS Part D Spending, openFDA, and HRSA 340B OPAIS. Prices reflect National Average Drug Acquisition Cost and may not represent actual transaction prices. This information is for research and comparison purposes only. Consult your pharmacist or benefits consultant for plan-specific pricing.